← Back
Data updated: Mar 29, 2026
MUTUAL PHARM
CardiovascularInfectious Disease
Generics
MUTUAL PHARM is a generic drug manufacturer focused on Cardiovascular, Infectious Disease.
1972
Since
24
Drugs
-
Trials
593
Approved (2yr)
Key Drugs
No active drugs
Top Drug Revenues Pro
Loading...
Revenue Over Time Pro
Loading...
Recent Activity
DOXYCYCLINE HYCLATE 2026-02-19
METRONIDAZOLE 2026-02-17
Labeling
METRONIDAZOLE 2026-02-17
Labeling
METRONIDAZOLE 2026-02-13
SULFAMETHOXAZOLE AND TRIMETHOPRIM 2026-02-10
Labeling
DOXYCYCLINE HYCLATE 2026-02-06
Labeling
DOXYCYCLINE HYCLATE 2026-02-06
Labeling
DOXYCYCLINE HYCLATE 2026-01-26
Labeling
SEC Filings
Pro
Loading...
Therapeutic Areas
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Cardiovascular 50%
1 drugs
Infectious Disease 50%
1 drugs
Pipeline Forecast
Loading...
Loading...
Upcoming Trial Milestones Pro
Loading...
Patent Cliff Pro
Loading...
Loading...
Loading...
Competitors by Therapeutic Area
Active (2)
Discontinued (22)
METRONIDAZOLE SULFAMETHOXAZOLE AND TRIMETHOPRIM OXYCODONE AND ACETAMINOPHEN AMITRIPTYLINE HYDROCHLORIDE HYDROCODONE BITARTRATE AND ACETAMINOPHEN LORAZEPAM ACETAMINOPHEN AND CODEINE PHOSPHATE HYDROXYZINE HYDROCHLORIDE DIPHENHYDRAMINE HYDROCHLORIDE ALLOPURINOL PREDNISONE METOCLOPRAMIDE HYDROCHLORIDE SPIRONOLACTONE HYDRALAZINE HYDROCHLORIDE INDOMETHACIN SULFAMETHOXAZOLE AND TRIMETHOPRIM DOUBLE STRENGTH THIORIDAZINE HYDROCHLORIDE SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE CHLORTHALIDONE PROPOXYPHENE NAPSYLATE AND ACETAMINOPHEN PROPOXYPHENE HYDROCHLORIDE ERGOLOID MESYLATES
Company Info
- First Approval
- 1972-11-14
- Latest
- 2016-05-09
- Applications
- 58